Asepsis Announces the U.S. Patent Grant No. 10,625,026 for its Autogenic Momentum Injection Device.

Asepsis Medical Technologies announces the U.S. Patent Grant for the Momenta-Dose™ forcé actuated injection device. The Momenta Dose™ is designed to administer rapid small volume subcutaneous or intramuscular injections, solely by a user’s applied force and subsequent momentum created. (read more)

Previous ArticleNext Article